Cosmetic Treatment Fillers

Here is a chart to view all the fillers used in cosmetic treatments and surgery's. This list is pretty complete but a lot of these are most likely outdated or not in use anymore. Visit this link to find more information. If your interested in the cosmetic treatment of Lipoatrophy http://www.clinicestetica.com/ was founded in 2001 to create seeking non-surgical permanent and semi-permanent solutions for cosmetic and reconstructive procedures, using a wide selection of products with proven safety and efficiency from around the world.

Product Name	Substance Type	Common Use	Claimed Effective Lifespan
Achyal	Hyaluronic acid	Lips	Over 24 months
Aquamid	Hhydrogel	Wrinkles, glabellar frowns, nasolabial folds, the depressed corners of the mouth, Lip augmentation	Over 24 months
Artecoll	Round PMMA beads in a bovine collagen	Nasal labial folds, Lips, Wrinkles and scars	Over 24 months
Bio-Alcamid	Poly-Alkyl-Imide	Facial defining and improving scars	Over 24 months
Cymetra	Human tissue	lips, nasolabial folds, deep wrinkles and fine lines, as well as acne and depressed scars.	3 to 6 months
Dermalive	Irregular PMMA beads in hyaluronic acid	Lips and fine lines and wrinkles	Over 24 months
Dermalive Deep	Irregular PMMA beads in hyaluronic acid	Nasal labial folds and deep wrinkles	Up to 12 months
Evolence™	Porcine (Pig) Collagen	Nasal labial folds, lips and other lines	Over 24 months
Evolution	Polyacrylamide copolymer gel	Nasal labial folds, lips and other lines	3 to 6 months
Hylaform	Hyaluronic acid	Nasal labial folds, lines at the side of the mouth.	3 to 6 months
Hylaform Fineline	Hyaluronic acid	Nasal labial folds, lines at the side of the mouth.	3 to 6 months
Hylaform Plus	Hyaluronic acid	Deeper folds and lips	3 to 6 months
Newfill	Polylactic acid	fine lines, wrinkles and more marked furrows or creases	18-24 months
Outline	Polyacrylamide copolymer gel	Nasal labial folds, lips and other lines	18months to 5 years
Radiesse	CaHA microspheres	fine lines, wrinkles and more marked furrows or creases	2 to 5 years
Restylane Perlane	Non-animal, stabilised hyaluronic acid	Facial contours such as cheeks and chin. Deep folds. Volume lip augmentation.	6-8 months
Restylane	Non-animal, stabilised hyaluronic acid	Wrinkle correction Lip enhancements	6-8 months
Restylane Fine Lines	Non-animal, stabilised hyaluronic acid	Thin superficial lines around eyes, mouth, forehead & smile lines.	6-8 months
Sculptra	Polylactic acid	Nasal labial folds, corners of mouth,cheeks & chin, scars.	18-24 months
Surgiderm	Hyaluronic Acid	Nasal labial folds, corners of mouth,cheeks & chin, scars.	18-24 months
Zyderm 1	Bovine collagen	Fine lines and wrinkles	18-24 months
Zyderm 2	Bovine collagen	Fine lines and wrinkles	1-4 months
Zyplast	Bovine collagen	Deeper lines and lips	1-4 months

HIV Drug Combination Invirase Plus Norvir Can Cause Life Threatening Heart Problems

HIV antiviral medication Invirase (saquinavir) when taken in combination with Norvir (ritonavir), also an HIV antiviral, can increase the risk of life-threatening heart rhythm abnormalities, triggering the FDA (Food and Drug Administration) to announce the addition of new safety information to Invirase's labeling. Saquinivir is a protease inhibitor class medication which is marketed in two formulations, hard-ger capsule formulation of the mesylate (Invirase) - taken with ritonavir to increase saquiavir's bioavailability, and a soft-gel capsule (Fortovase).
In February of this year the FDA warned clinicians and patients that the drug combination could cause QT and PR interval prolongation (electrocardiogram heart rhythm activity indicators). QT interval refers to a measure (time) between the start of the Q wave and the end of the T wave in the heart's electrical cycle. The PR interval shows how long the electrical impulse takes to travel from the sinus node through the AV node and entering the ventricles (in the heart).
Patients with QT prolongation can develop torsades de pointes, a type of ventricular tachycardia that exhibits distinct characteristics on the electrocardiogram (abnormal heart rhythm). There is a higher risk of ventricular fibrillation, an irregular heart rhythm which can be fatal. Patients with torsades de pointes may experience lightheadedness or fainting.
PR interval prolongation can lead to heart block (or AV block), and the patient may experience lightheadedness, syncope (fainting), and palpitations. Heart block is an electrical fault in the heart.
The FDA announced that there will also be a medication guide for individuals taking Invirase; the guide will explain these possible risks. Patients with existing heart rate/rhythm problems, as well as those with underlying heart conditions are have a higher risk of developing one of the serious heart events described above.
Edward Cox, M.D., M.P.H, director, Office of Antimicrobial Products in FDA's Center for Drug Evaluation and Research, said:

"These heart conditions could potentially be life-threatening and we want to assure that health care providers and patients are adequately informed of the risks. Patients should talk to their doctor if they have any concerns about their treatment. Certain drugs may interact with Invirase and increase the risk of developing these side effects, so patients should be sure to tell their doctor about other medicines they may be taking, including non-prescription medicines, vitamins, and herbal supplements.

Side effects from Invirase use experienced by patients or identified by clinicians should be reported to the FDA's MedWatch program.
Invirase, which is sometimes used with other medications for HIV treatment, apart from Norvir, was approved by the FDA in 1995.
In a communiqué, the FDA emphasizes that Invirase does not cure or prevent HIV infection, neither does it prevent the transmission of HIV infection to other people.
Invirase is manufactured and marketed by Genentech (part of Roche Group), San Francisco, California, and Norvir is manufactured and marketed by Abbot Laboratories, Abbot Park, Illinois.